Ma Songjiang

CIK 00019855471 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001985547

Recent Transactions

50 trades

Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-28$10.07/sh−558→ 2,806,084 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-27$10.28/sh−2,000→ 2,806,642 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-23$10.24/sh−182→ 2,808,642 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-22$10.97/sh−2,000→ 2,808,824 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-21$10.83/sh−2,000→ 2,810,824 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-20$11.25/sh−2,000→ 2,812,824 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-19$11.11/sh−2,000→ 2,814,824 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-16$11.31/sh−2,000→ 2,816,824 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-15$10.68/sh−2,000→ 2,818,824 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-14$11.30/sh−20→ 2,820,824 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-13$11.37/sh−2,000→ 2,820,844 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-05-12$10.56/sh−2,000→ 2,822,844 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-21$10.00/sh−174→ 2,824,844 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-20$10.09/sh−2,000→ 2,825,018 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-19$10.13/sh−2,000→ 2,827,018 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-18$10.24/sh−242→ 2,829,018 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-17$12.09/sh−2,000→ 2,829,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-14$12.31/sh−2,000→ 2,831,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-13$11.80/sh−2,000→ 2,833,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-12$11.74/sh−2,000→ 2,835,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-11$11.40/sh−2,000→ 2,837,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-10$10.14/sh−2,000→ 2,839,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-07$10.13/sh−1,906→ 2,841,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-07$12.14/sh−41→ 2,843,166 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-07$13.03/sh−53→ 2,843,207 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-06$10.80/sh−2,000→ 2,843,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-05$10.98/sh−2,000→ 2,845,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-04$10.86/sh−2,000→ 2,847,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-03-03$11.23/sh−2,000→ 2,849,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-28$11.41/sh−2,000→ 2,851,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-27$11.33/sh−2,000→ 2,853,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-26$11.63/sh−2,000→ 2,855,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-25$11.37/sh−2,000→ 2,857,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-24$11.52/sh−187→ 2,859,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-24$10.60/sh−1,813→ 2,859,447 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-21$11.84/sh−1,818→ 2,861,442 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-21$12.60/sh−182→ 2,861,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-20$12.40/sh−2,000→ 2,863,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-19$12.29/sh−2,000→ 2,865,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-18$12.49/sh−2,000→ 2,867,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-14$11.94/sh−2,000→ 2,869,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-13$11.69/sh−2,000→ 2,871,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-12$11.49/sh−2,000→ 2,873,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-11$11.52/sh−1,878→ 2,875,260 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-10$11.90/sh−2,000→ 2,877,138 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-07$12.16/sh−2,000→ 2,879,158 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-06$12.85/sh−2,000→ 2,881,138 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-05$12.84/sh−20→ 2,883,138 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-05$12.39/sh−1,980→ 2,883,158 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2025-02-04$11.62/sh−2,000→ 2,885,138 total

Companies

GYRE THERAPEUTICS, INC.
Director, President
$GYRE

Recent Filings

Address

C/O GYRE THERAPEUTICS, INC. 12770 HIGH BLUFF DRIVE, SUITE 150

SAN DIEGO, CA, 92130

View on SEC.gov